NantHealth (NASDAQ:NH) Coverage Initiated at StockNews.com
NantHealth (NASDAQ:NH) Coverage Initiated at StockNews.com
Research analysts at StockNews.com started coverage on shares of NantHealth (NASDAQ:NH – Get Rating) in a report issued on Sunday. The firm set a "hold" rating on the stock.
StockNews.com的研究分析师开始报道以下股票 NantHealth(纳斯达克股票代码:NH — 获取评级) 在周日发布的报告中。该公司对该股设定了 “持有” 评级。
NantHealth Price Performance
nanHealth 价格表现
NASDAQ:NH opened at $1.46 on Friday. The firm has a market capitalization of $11.20 million, a P/E ratio of -0.19 and a beta of 1.82. NantHealth has a 1-year low of $1.24 and a 1-year high of $11.85. The company's fifty day moving average price is $2.12 and its 200-day moving average price is $1.99.
纳斯达克股票代码:NH 周五开盘价为 1.46 美元。该公司的市值为1120万美元,市盈率为-0.19,beta值为1.82。NantHealth的1年低点为1.24美元,为1年来的最高水平,为11.85美元。该公司的五十天移动平均价格为2.12美元,其200天移动平均线价格为1.99美元。
Hedge Funds Weigh In On NantHealth
对冲基金对 nanHealth 进行权衡
Institutional investors have recently bought and sold shares of the company. Goldman Sachs Group Inc. acquired a new position in shares of NantHealth in the second quarter valued at approximately $36,000. Millennium Management LLC acquired a new position in NantHealth during the 2nd quarter worth approximately $110,000. Finally, Atria Wealth Solutions Inc. purchased a new stake in shares of NantHealth during the 1st quarter worth approximately $170,000. 4.50% of the stock is owned by hedge funds and other institutional investors.
机构投资者最近买入和卖出了该公司的股票。高盛集团公司在第二季度收购了NanThealth股票的新头寸,价值约为36,000美元。千禧管理有限责任公司在第二季度收购了NanThealth的新职位,价值约11万美元。最后,Atria Wealth Solutions Inc.在第一季度购买了价值约17万美元的NantHealth股票的新股份。该股的4.50%由对冲基金和其他机构投资者持有。
NantHealth Company Profile
NanHealth 公司简介
(Get Rating)
(获取评分)
NantHealth, Inc is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment.
NantHealth, Inc是一家基于证据的个性化医疗保健公司,致力于为癌症等关键疾病提供治疗。该公司支持治疗决策,改善患者预后,验证治疗方案,提供高质量的护理,降低成本,确保适当的报销,并简化实施和部署。
Featured Articles
精选文章
- Get a free copy of the StockNews.com research report on NantHealth (NH)
- Insiders Drive Volatility For Keurig Dr Pepper
- After a 40% Drop, Analysts Remain Bullish on Impinj
- Visa Charges Higher After Better-Than-Expected Q2 Report
- onsemi Puts A Bottom in Chip Stocks, Heads For New Highs
- Can Teladoc Stock Be Resuscitated?
- 免费获取 StockNews.com 关于 NantHealth(NH)的研究报告的副本
- 业内人士推动了Keurig Pepper博士的波动性
- 在下跌40%之后,分析师仍然看好Impinj
- 第二季度报告好于预期后,签证费用上涨
- onsemi将芯片股触底,创下新高
- Teladoc 股票能否复苏?
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.
接收 NanHealth Daily 的新闻和收视率 -在下面输入您的电子邮件地址,通过Marketbeat.com的免费每日电子邮件时事通讯接收NantHealth及相关公司最新新闻和分析师评级的简明每日摘要。